agilon health, inc. (NYSE:AGL - Get Free Report) shares dropped 5.3% on Thursday . The company traded as low as $4.15 and last traded at $4.17. Approximately 1,123,403 shares traded hands during trading, a decline of 80% from the average daily volume of 5,738,973 shares. The stock had previously closed at $4.40.
Analyst Ratings Changes
A number of equities analysts recently commented on the stock. Needham & Company LLC reaffirmed a "hold" rating on shares of agilon health in a research report on Friday. Macquarie began coverage on shares of agilon health in a report on Monday, December 16th. They set a "neutral" rating and a $3.00 target price on the stock. Citigroup upgraded agilon health from a "sell" rating to a "neutral" rating and boosted their price target for the company from $1.75 to $2.25 in a research note on Friday, January 10th. Sanford C. Bernstein raised their price objective on agilon health from $2.50 to $3.15 and gave the stock a "market perform" rating in a research note on Wednesday, January 15th. Finally, Stifel Nicolaus lifted their price objective on agilon health from $2.00 to $3.00 and gave the company a "hold" rating in a report on Wednesday, February 26th. Two investment analysts have rated the stock with a sell rating, thirteen have given a hold rating and two have issued a buy rating to the company. According to MarketBeat, the stock has an average rating of "Hold" and an average target price of $3.95.
Check Out Our Latest Report on agilon health
agilon health Price Performance
The business's 50-day simple moving average is $3.51 and its two-hundred day simple moving average is $2.94. The stock has a market cap of $1.90 billion, a price-to-earnings ratio of -4.90 and a beta of 0.67. The company has a debt-to-equity ratio of 0.06, a current ratio of 1.29 and a quick ratio of 1.29.
Hedge Funds Weigh In On agilon health
Several large investors have recently bought and sold shares of AGL. Captrust Financial Advisors raised its holdings in agilon health by 10.9% in the 4th quarter. Captrust Financial Advisors now owns 35,485 shares of the company's stock valued at $67,000 after buying an additional 3,494 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its holdings in shares of agilon health by 2.5% during the fourth quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 206,991 shares of the company's stock worth $393,000 after purchasing an additional 5,107 shares during the period. MetLife Investment Management LLC increased its holdings in agilon health by 4.0% in the fourth quarter. MetLife Investment Management LLC now owns 174,551 shares of the company's stock valued at $332,000 after purchasing an additional 6,762 shares during the period. Symphony Financial Services Inc. raised its position in agilon health by 44.3% during the 4th quarter. Symphony Financial Services Inc. now owns 23,000 shares of the company's stock worth $44,000 after purchasing an additional 7,058 shares during the last quarter. Finally, Point72 Asia Singapore Pte. Ltd. bought a new stake in shares of agilon health in the 3rd quarter valued at about $28,000.
About agilon health
(
Get Free Report)
agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.
Read More
Before you consider agilon health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and agilon health wasn't on the list.
While agilon health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
